For most pharmaceutical companies, extracting insight from heterogeneous and ambiguous data remains a challenge. The era of data-driven R&D is motivating investment in technologies such as machine learning to provide deeper insights into new drug development strategies.
The quality of data directly impacts the accuracy and reliability of the results of computational approaches. However, the work required to achieve clean, high-quality data can be costly, often prohibitively so, requiring data scientists to spend the majority of their time as ‘data janitors’, rather than actually analysing data.
SciBite provides an integrated, cost-effective solution to significantly reduce the time and cost associated with the process of data cleansing, normalisation and annotation. The output ensures that downstream integration and discovery activities are based on high-quality, contextualised data.
To learn more, download the full use case.
![]() |
![]() |
Large language models (LLMs) have limitations when applied to search due to their inability to distinguish between fact and fiction, potential privacy concerns, and provenance issues. LLMs can, however, support search when used in conjunction with FAIR data and could even support the democratisation of data, if used correctly…
Read![]() |
![]() |
In a world where technology plays an increasingly pivotal role in shaping our lives, it is crucial to recognize the contributions of women and the importance of empowering the next generation of female tech professionals.
ReadGet in touch with us to find out how we can transform your data
© SciBite Limited / Registered in England & Wales No. 07778456